BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lung
,
Metabolism of nitric oxide
,
Fluoxetine
,
rs3825942
,
SNCA
,
Angiogenesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Spliceosomes
(tissue)
Summary
General Info
Body Atlas
Curated Studies
Most Correlated Studies
Cervical cancer HeLa cells with TCAB1 or USPL1 siRNA knockdown
Embryonic kidney HEK293 cells with siRNA-mediated knockdowns of RBM17, U2SURP, and CHERP
Ovarian cancer A2780 cells with siRNA-mediated DDX23 knockdown
Hematopoietic stem cells (HSC) and myeloid progenitors from SRSF2 conditional knock-in mice
Ovarian cancer A2780 cells with shRNA-mediated USP39 knockdown
Explore Curated Studies Results
Literature
Most Relevant Literature
The significant other: splicing by the minor spliceosome.
Enantioselective total synthesis of pladienolide B: a potent spliceosome inhibitor.
Spliceosome mutations in hematopoietic malignancies.
A unique spatial arrangement of the snRNPs within the native spliceosome emerges from in silico stud…
The spliceosome as a target of novel antitumour drugs.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Patient Response to Immunotherapy Using Spliceosome Mutational Markers (PRISMM)
Prognostic Molecular Markers in Patients With Myelodysplastic Syndrome
Dose Escalation/ Expansion Trial of CA-4948 as Monotherapy and in Combination With Azacitidine or Ve…
Alternative Splicing and Leukemia Initiating Cells
Imetelstat Sodium in Treating Patients With Primary or Secondary Myelofibrosis
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ